Kapstone Financial Advisors LLC Reduces Stock Position in CVS Health Co. (NYSE:CVS)

Kapstone Financial Advisors LLC trimmed its holdings in shares of CVS Health Co. (NYSE:CVS) by 5.9% in the fourth quarter, HoldingsChannel reports. The firm owned 5,322 shares of the pharmacy operator’s stock after selling 336 shares during the period. Kapstone Financial Advisors LLC’s holdings in CVS Health were worth $383,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Stonebrook Private Inc. purchased a new position in shares of CVS Health during the 4th quarter worth approximately $241,000. Sector Gamma AS purchased a new position in shares of CVS Health during the 4th quarter worth approximately $17,292,000. Unique Wealth Strategies LLC purchased a new position in shares of CVS Health during the 4th quarter worth approximately $857,000. Schwarz Dygos Wheeler Investment Advisors LLC increased its stake in shares of CVS Health by 15.0% during the 4th quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 21,849 shares of the pharmacy operator’s stock worth $1,725,000 after purchasing an additional 2,857 shares in the last quarter. Finally, Alexander Randolph Advisory Inc. purchased a new stake in CVS Health in the 4th quarter worth approximately $4,410,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CVS has been the subject of several recent analyst reports. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Wells Fargo & Company lowered their target price on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research note on Monday, April 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research note on Wednesday, April 10th. Finally, Barclays began coverage on shares of CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $89.44.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.24% of the stock is owned by company insiders.

CVS Health Stock Down 0.2 %

Shares of CVS Health stock traded down $0.15 during trading on Friday, reaching $67.18. The company had a trading volume of 6,396,438 shares, compared to its average volume of 8,376,818. The company has a market cap of $84.68 billion, a price-to-earnings ratio of 10.40, a price-to-earnings-growth ratio of 0.89 and a beta of 0.52. The firm’s fifty day moving average is $74.42 and its 200-day moving average is $73.66. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. The business had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.99 EPS. On average, analysts anticipate that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.96%. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.